Mylan

Pharma major Mylan to launch remdesivir in India by July end, at Rs 4,800 per vial

Pharma major Mylan to launch remdesivir in India by July end, at Rs 4,800 per vial

From our online archive

07 Jul 2020

2 min read

Four Indian firms ink licensing pact with Gilead for COVID-19 drug Remdesivir

Four Indian firms ink licensing pact with Gilead for COVID-19 drug Remdesivir

From our online archive

14 May 2020

2 min read

USFDA okays Mylan, Biocon's biosimilar of cancer drug Herceptin

USFDA okays Mylan, Biocon's biosimilar of cancer drug Herceptin

From our online archive

02 Dec 2017

2 min read

Mylan gets DCGI nod to launch HIV drug in India

Mylan gets DCGI nod to launch HIV drug in India

From our online archive

08 Aug 2017

1 min read

Competition Commission of India orders probe into Roche cancer drug

Competition Commission of India orders probe into Roche cancer drug

From our online archive

26 Apr 2017

2 min read

You cannot hang on to breast cancer drug, Delhi HC tells Roche

You cannot hang on to breast cancer drug, Delhi HC tells Roche

From our online archive

22 Feb 2017

2 min read

X

The New Indian Express

www.newindianexpress.com